Albert W. Brzeczko - Mar 16, 2022 Form 4 Insider Report for ACURA PHARMACEUTICALS, INC (ACUR)

Role
VP, Pharma Sciences - APT
Signature
/s/ Albert W. Brzeczko
Stock symbol
ACUR
Transactions as of
Mar 16, 2022
Transactions value $
$0
Form type
4
Date filed
3/18/2022, 04:05 PM
Next filing
Aug 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACUR Restricted Stock Unit Award +40K +51.73% 117K Mar 16, 2022 Common Stock 40K $0.01 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded under the Acura Pharmaceuticals Inc. 2021 Restricted Stock Unit Award Plan (the "Plan").
F2 Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock.
F3 100% of Restricted Stock Units vest on December 31, 2022 or earlier if Reporting Person's service as an employee of Issuer is terminated by Issuer without Cause (as defined in the Plan) or due to Reporting Person's death or Disability (as defined in the Plan) or a qualifying change of control occurs. Distributions in respect of vested Restricted Stock Units will be made in three equal installments on the first business day of each of January 2024, 2025, and 2026 or earlier upon a qualifying change of control which also meets certain criteria of Section 409A of the Internal Revenue Code.
F4 Not Applicable.